137259-44-0

Upstream product

• 598-21-0 2-Bromoacetyl bromide 
• 138397-85-0 iminodiacetic acid dibenzylester 
• 13094-51-4 bromoacetic anhydride 

Downstream Products

• 918334-48-2 {[(adenin-9-yl)acetyl]imino}diacetic acid dibenzyl ester 
• 918334-49-3 {[(N⁶-methyladenin-9-yl)acetyl]imino}diacetic acid dibenzyl ester 
• 141997-01-5 tetradecanoic acid 2-([(bis-benzyloxycarbonylmethyl-carbamoyl)-methyl]-{2-[[(bis-benzyloxycarbonylmethyl-carbamoyl)-methyl]-(2-tetradecanoyloxy-ethyl)-amino]-ethyl}-amino)-ethyl ester 
• 1026971-82-3 N,N'-bis(2-hexanoyloxyethyl)-N,N'-bis-1,2-ethanediamine 
• 238099-18-8 N,N'-bis(2-butyryloxyethyl)-N,N'-bis-1,2-ethanediamine 
• 238099-21-3 N-(2-butyryloxyethyl)-N'-(2-ethyloxyethyl)-N,N-bis-1,2-ethanediamine 
• 238099-17-7 N,N'-bis(2-propionyloxyethyl)-N,N'-bis-1,2-ethanediamine 
• 238099-20-2 N-(2-butyryloxyethyl)-N'-(2-hydroxyethyl)-N,N-bis-1,2-ethanediamine 
• 238099-16-6 N,N'-bis(2-acetyloxyethyl)-N,N'-bis-1,2-ethanediamine 

Relevant academic research and scientific papers

Synthesis of potential purinoceptor antagonists: Application of P1-tBU phosphazene base for alkylation of adenine in solution and on solid phase

Alkylation of adenine in solution and on solid phase was accelerated by phosphazene base P1-tBu compared to mineral bases. The reactions in solution afforded regioselectively the appropriate N9-alkylated adenines with high preparative yields while the rea

Methods of diagnostic image analysis using lipophilic contrast agents

The present invention relates to contrast enhancing agents, conjugates thereof, pharmaceutical compositions thereof, and methods for diagnostic analysis, particularly NMR image analysis using these agents. The contrast enhancing agents are chelates of par